ALTAIR NANOTECHNOLOGIES INC
Materials · Miscellaneous Chemical Products · Z4 · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY16 | FY15 | FY12 | FY11 | FY10 | FY09 | |
|---|---|---|---|---|---|---|
| Revenue | $54.7M | $14.3M | $1.5M | $5.2M | $7.8M | $4.4M |
| Operating income | −$3.2M | −$15.5M | −$18.6M | −$21.1M | −$20.5M | −$20.8M |
| Net income | −$3.6M | −$19.5M | −$18.0M | −$19.9M | −$22.3M | −$21.3M |
| Total assets | $162.9M | $134.2M | $66.4M | $63.5M | $24.3M | — |
| Total liabilities | $179.4M | $147.3M | $29.8M | $10.1M | $7.0M | — |
| Equity | −$16.4M | −$13.2M | $36.6M | $53.5M | $17.3M | $36.2M |
| EPS (diluted) | — | — | — | — | — | — |
| Shares out. | 11.6M | 11.6M | 69.5M | 11.6M | 27.0M | 25.0M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2016- Operating margin
- −5.8%
- Net margin
- −6.7%
- Return on equity
- 22.2%
- Return on assets
- −2.2%
- Return on capital (ROCE)
- −6.5%
- Liabilities / assets
- 110.1%
- Debt / equity
- —
- Book value / share
- $-1.41
- Revenue growth (YoY)
- 283.0%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2016- Altman Z″ (distress)
- -7.90distress
- Accruals / assets
- −4.9%clean
- Beneish M-Score
- -1.57elevated
- Piotroski F-Score
- 6/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 severe● 4 warning● 4 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- High leverage (liabilities > 70% of assets)
- Beneish M-Score elevated — earnings-manipulation screen flag
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Apr 1, 2014
- NT 10-Qmissed a reporting deadline ↗Nov 15, 2013
- NT 10-Kmissed a reporting deadline ↗Apr 3, 2001
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2000
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Director / officer change · Other material eventOct 2, 2015
- Changed auditorApr 7, 2015
- Prior financials not reliable (restatement)Mar 13, 2015
- Entered a material agreementFeb 2, 2015
- Director / officer changeSep 16, 2014
- Delisting / listing-standard notice · Regulation FD disclosureSep 15, 2014
- Changed auditorSep 4, 2014
- Delisting / listing-standard notice · Director / officer changeAug 19, 2014
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 15-12BFORM 15-12BMay 19, 2017
- 10-KFORM 10-KMay 18, 2017
- EFFECTMay 16, 2017
- S-8 POSFORM S-8 POSMay 15, 2017
- S-8 POSFORM S-8 POSMay 15, 2017
- S-8 POSFORM S-8 POSMay 15, 2017
- POS AMFORM POS AMMay 15, 2017
- CT ORDERMay 3, 2017
- REVOKEDNov 17, 2016
- 10-QFORM 10-QNov 16, 2016
- 10-QFORM 10-QNov 16, 2016
- 10-QFORM 10-QNov 16, 2016
- 10-KFORM 10-KNov 16, 2016
- 8-KFORM 8-KOct 2, 2015
- 8-KFORM 8-KApr 7, 2015